These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8469325)

  • 21. Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.
    Foroutan P; Murray ME; Fujioka S; Schweitzer KJ; Dickson DW; Wszolek ZK; Grant SC
    Radiology; 2013 Jan; 266(1):280-8. PubMed ID: 23151826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aluminum deposition in the central nervous system tissues of patients with Parkinson's disease].
    Yasui M; Kihira T; Ota K; Mukoyama M; Adachi K
    Rinsho Shinkeigaku; 1991 Oct; 31(10):1095-8. PubMed ID: 1802464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of neurotensin-like immunoreactivity in human basal ganglia: increased neurotensin levels in substantia nigra in Parkinson's disease.
    Fernandez A; Jenner P; Marsden CD; De Ceballos ML
    Peptides; 1995; 16(2):339-46. PubMed ID: 7784265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efferent connections of the caudate nucleus, including cortical projections of the striatum and other basal ganglia: an autoradiographic and horseradish peroxidase investigation in the cat.
    Royce GJ; Laine EJ
    J Comp Neurol; 1984 Jun; 226(1):28-49. PubMed ID: 6736295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease.
    Chen JC; Hardy PA; Kucharczyk W; Clauberg M; Joshi JG; Vourlas A; Dhar M; Henkelman RM
    AJNR Am J Neuroradiol; 1993; 14(2):275-81. PubMed ID: 8456699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High resolution MRI of the deep gray nuclei at 8 Tesla.
    Bourekas EC; Christoforidis GA; Abduljalil AM; Kangarlu A; Chakeres DW; Spigos DG; Robitaille PM
    J Comput Assist Tomogr; 1999; 23(6):867-74. PubMed ID: 10589560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
    Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
    Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J
    Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance.
    Ye FQ; Allen PS; Martin WR
    Mov Disord; 1996 May; 11(3):243-9. PubMed ID: 8723139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.
    Brooks DJ; Luthert P; Gadian D; Marsden CD
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):108-11. PubMed ID: 2709018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
    Rinne JO; Anichtchik OV; Eriksson KS; Kaslin J; Tuomisto L; Kalimo H; Röyttä M; Panula P
    J Neurochem; 2002 Jun; 81(5):954-60. PubMed ID: 12065607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of R2 with total iron concentration in the brains of rhesus monkeys.
    Hardy PA; Gash D; Yokel R; Andersen A; Ai Y; Zhang Z
    J Magn Reson Imaging; 2005 Feb; 21(2):118-27. PubMed ID: 15666406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation effect of substantia nigra iron deposition and functional connectivity on putamen glucose metabolism in Parkinson's disease.
    Zang Z; Song T; Li J; Yan S; Nie B; Mei S; Ma J; Yang Y; Shan B; Zhang Y; Lu J
    Hum Brain Mapp; 2022 Aug; 43(12):3735-3744. PubMed ID: 35471638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.